Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
91,837,471
-
Total 13F shares
-
57,034,586
-
Share change
-
+53,099,609
-
Total reported value
-
$114,325,460
-
Price per share
-
$2.00
-
Number of holders
-
34
-
Value change
-
+$107,182,399
-
Number of buys
-
27
-
Number of sells
-
12
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q2 2024
As of 30 Jun 2024,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,034,586 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, Deep Track Capital, LP, Nextech Invest Ltd., Avidity Partners Management LP, Blue Owl Capital Holdings LP, VANGUARD GROUP INC, Driehaus Capital Management LLC, Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., and Ally Bridge Group (NY) LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.